These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 6608450

  • 1. Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b-binding protein.
    Saint-Remy JM.
    Eur J Immunol; 1984 Mar; 14(3):254-9. PubMed ID: 6608450
    [Abstract] [Full Text] [Related]

  • 2. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 3. A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway).
    Thielens NM, Colomb MG.
    Eur J Immunol; 1986 Jun; 16(6):617-22. PubMed ID: 3487454
    [Abstract] [Full Text] [Related]

  • 4. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E, Kazatchkine MD, Mecarelli-Halbwachs L.
    Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
    [Abstract] [Full Text] [Related]

  • 5. Regulation and deregulation of the fluid-phase classical pathway C3 convertase.
    Gigli I, Sorvillo J, Halbwachs-Mecarelli L.
    J Immunol; 1985 Jul; 135(1):440-4. PubMed ID: 3158705
    [Abstract] [Full Text] [Related]

  • 6. Activation of the classical pathway of human complement by a human monoclonal IgE, IgE(DES).
    Saint-Remy JM, Magnusson CG, Masson PL.
    J Immunol; 1983 Mar; 130(3):1341-4. PubMed ID: 6822738
    [Abstract] [Full Text] [Related]

  • 7. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW, Kadlec JV, Petrella EC, Bredehorst R, Vogel CW.
    Cancer Res; 1993 Feb 01; 53(3):592-9. PubMed ID: 8425193
    [Abstract] [Full Text] [Related]

  • 8. Relationship between the component and regulatory proteins of the classical pathway C3 convertase.
    Welch TR, Forristal J, Beischel L.
    J Lab Clin Med; 1986 Jun 01; 107(6):529-33. PubMed ID: 3635565
    [Abstract] [Full Text] [Related]

  • 9. Generation of the classical pathway C3 convertase (EAC4b2a) by proteolytic enzymes.
    Loos M, Heinz HP.
    Acta Pathol Microbiol Immunol Scand Suppl; 1984 Jun 01; 284():67-74. PubMed ID: 6375257
    [Abstract] [Full Text] [Related]

  • 10. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV, Shibanova ED, Zinchenko AA.
    Biokhimiia; 1987 Apr 01; 52(4):660-6. PubMed ID: 3647798
    [Abstract] [Full Text] [Related]

  • 11. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ.
    J Immunol; 1986 May 01; 136(9):3378-83. PubMed ID: 3485688
    [Abstract] [Full Text] [Related]

  • 12. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
    Gigli I, Fujita T, Nussenzweig V.
    Proc Natl Acad Sci U S A; 1979 Dec 01; 76(12):6596-600. PubMed ID: 293746
    [Abstract] [Full Text] [Related]

  • 13. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR, Hazevoet HM, Hermans J, van Es LA, Cats A.
    Clin Exp Immunol; 1983 Oct 01; 54(1):248-52. PubMed ID: 6604610
    [Abstract] [Full Text] [Related]

  • 14. Relative resistance of the F-42-stabilized classical pathway C3 convertase to inactivation by C4-binding protein.
    Daha MR, van Es LA.
    J Immunol; 1980 Nov 01; 125(5):2051-4. PubMed ID: 6903579
    [Abstract] [Full Text] [Related]

  • 15. A cluster of positively charged amino acids in the alpha-chain of C4b-binding protein (C4BP) is pivotal for the regulation of the complement system and the interaction with bacteria.
    Blom AM.
    Scand J Clin Lab Invest Suppl; 2000 Nov 01; 233():37-49. PubMed ID: 11317941
    [Abstract] [Full Text] [Related]

  • 16. A single arginine to tryptophan interchange at beta-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. Implications for the location of a C5 binding site in C4.
    Ebanks RO, Jaikaran AS, Carroll MC, Anderson MJ, Campbell RD, Isenman DE.
    J Immunol; 1992 May 01; 148(9):2803-11. PubMed ID: 1573269
    [Abstract] [Full Text] [Related]

  • 17. Role of the C3b-binding site on C4b-binding protein in regulating classical pathway C5 convertase.
    Rawal N, Pangburn MK.
    Mol Immunol; 2007 Feb 01; 44(6):1105-14. PubMed ID: 16979240
    [Abstract] [Full Text] [Related]

  • 18. Isolation of C4-binding protein from guinea pig plasma and demonstration of its function as a control protein of the classical complement pathway C3 convertase.
    Burge J, Nicholson-Weller A, Austen KF.
    J Immunol; 1981 Jan 01; 126(1):232-5. PubMed ID: 6778916
    [Abstract] [Full Text] [Related]

  • 19. Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertase.
    Sobel AT, Cooper NR, Schreiber RD.
    J Immunol; 1979 Jan 01; 122(1):34-8. PubMed ID: 762421
    [Abstract] [Full Text] [Related]

  • 20. Activation of the classical pathway of complement by the C3NeF-stabilized cell-bound amplification convertase.
    Daha MR, van Es LA.
    J Immunol; 1979 Mar 01; 122(3):801-5. PubMed ID: 448075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.